Collaboration to raise global visibility for Upstream issuers as they begin listing on Upstream’s next generation securities market
IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content syndication platform, is pleased to announce a strategic media collaboration with Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”). The collaboration works to raise visibility for the influx of issuers listing on Upstream’s blockchain-powered market.
As part of Upstream’s listing benefits, IBN is offering issuers a variety of tools to amplify awareness including press releases with article syndication to amplify coverage across IBN’s 5,000+ strategic syndication partners such as Apple News and StreetInsider, a detailed Market Awareness Profile (MAP), coverage via multiple investor-oriented newsletters, and discounted bolt-on solutions to expand reach to millions of investors.
“Upstream has seen an uptick in dual listing applications from NASDAQ, NYSE, OTC, and other international issuers eager to access a global audience who can trade U.S. equities using digital currency and other streamlined payment methods,” says Upstream co-founder Mark Elenowitz. “Collaborating with a modern firm like IBN provides our issuers with increased visibility around their listings and the opportunities Upstream’s blockchain-powered platform facilitates.”
“IBN has amplified corporate communications for 500+ client partners across multiple industries and sectors over the last 17 years,” says IBN Communications Director Jonathan Keim. “We believe working with Upstream expands our reach to forward-thinking issuers while adding strength to the public markets.”
Upstream, a MERJ Exchange Market (merj.exchange), is a fully regulated global stock exchange for digital securities and NFTs. Powered by Horizon’s Ethereum-L2 matching engine technology, the platform enables users to trade NFTs, and invest in securities for IPOs, crowdfunded companies, U.S. & international equities, and celebrity ventures using the Upstream app.
For more information, please visit https://upstream.exchange.
Upstream is currently accepting applications to dual list at https://upstream.exchange/getlisted.
IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com
Certain statements contained in this press release, including, without limitation, statements containing the words ‘’believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company’s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company’s ability to develop its proposed abuse deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company’s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Form S-1, Form 10-K for the year ended January 31, 2020 and Forms 10-Q, and the Company’s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.
This notice shall not constitute an offer to sell securities or the solicitation of an offer to buy securities in any jurisdiction where such offer or solicitation is not permitted.
*U.S. investors are not permitted to purchase Upstream listed securities. U.S. and Canadian citizens will only be able to trade in securities they currently own, that have been listed on Upstream, for liquidation purposes only.
Commemorative Dual Listing NFTs received have no economic value, royalties, equity ownership, or dividends. NFTs are for utility, collection, and display only.